(Q40369765)

19 September 2017

title

Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells (English)

1 reference

19 September 2017

0 references

0 references

1 reference

Mei Hong

1

1 reference

19 September 2017

Yoshihiro Murai

2

1 reference

19 September 2017

Tomohiko Kutsuna

3

1 reference

19 September 2017

Hiroyuki Takahashi

4

1 reference

19 September 2017

Kazuhiro Nomoto

5

1 reference

19 September 2017

Chun-Mei Cheng

6

1 reference

19 September 2017

Shin Ishizawa

7

1 reference

19 September 2017

Qing-Li Zhao

8

1 reference

19 September 2017

Ryohei Ogawa

9

1 reference

19 September 2017

Brian V Harmon

10

1 reference

19 September 2017

Koichi Tsuneyama

11

1 reference

19 September 2017

Yasuo Takano

12

1 reference

19 September 2017

publication date

23 September 2005

1 reference

Journal of Cancer Research and Clinical Oncology

19 September 2017

published in

1 reference

19 September 2017

volume

132

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

1-8

1 reference

Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation

19 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-005-0036-X

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-005-0036-X

Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00432-005-0036-X

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

21 January 2018

1 reference

12 December 2020

Human origin recognition complex binds to the region of the latent origin of DNA replication of Epstein-Barr virus

1 reference

12 December 2020

Use of adeno-associated viral vector for delivery of small interfering RNA.

1 reference

12 December 2020

Virally targeted therapies for EBV-associated malignancies

1 reference

12 December 2020

Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.

1 reference

12 December 2020

Suppression of Epstein-Barr virus-encoded latent membrane protein-1 by RNA interference inhibits the metastatic potential of nasopharyngeal carcinoma cells

1 reference

12 December 2020

Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital

1 reference

12 December 2020

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

1 reference

12 December 2020

An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene

1 reference

12 December 2020

Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus

1 reference

12 December 2020

Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes

1 reference

12 December 2020

Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice

1 reference

12 December 2020

Mapping EBNA-1 domains involved in binding to metaphase chromosomes.

1 reference

12 December 2020

Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells

1 reference

12 December 2020

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

1 reference

12 December 2020

Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site

1 reference

12 December 2020

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

1 reference

12 December 2020

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

1 reference

12 December 2020

Identity of the proliferating cell nuclear antigen and cyclin

1 reference

12 December 2020

Unlocking the potential of the human genome with RNA interference

1 reference

12 December 2020

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

1 reference

12 December 2020

Two deletions in the Epstein-Barr virus genome of the Burkitt lymphoma nonproducer line Raji

1 reference

12 December 2020

Killing the messenger: short RNAs that silence gene expression

1 reference

12 December 2020

Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site

1 reference

12 December 2020

Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.

1 reference

12 December 2020

Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells

1 reference

12 December 2020

Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections

1 reference

12 December 2020

Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure.

1 reference

12 December 2020

Sequence analysis of Raji Epstein-Barr virus DNA.

1 reference

12 December 2020

Inhibition of in vitro proliferation of Epstein Barr Virus infected B cells by an antisense oligodeoxynucleotide targeted against EBV latent membrane protein LMP1.

1 reference

12 December 2020

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

12 December 2020

Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein-Barr virus type I latency.

1 reference

12 December 2020

Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs

1 reference

12 December 2020

Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders

1 reference

12 December 2020

A system for stable expression of short interfering RNAs in mammalian cells

1 reference

12 December 2020

Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus

1 reference

12 December 2020

A promoter of Epstein-Barr virus that can function during latent infection can be transactivated by EBNA-1, a viral protein required for viral DNA replication during latent infection.

1 reference

12 December 2020

Epstein-Barr virus U leader exon contains an internal ribosome entry site

1 reference

12 December 2020

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

1 reference

12 December 2020

Replication of latent Epstein-Barr virus genomes in Raji cells

1 reference

12 December 2020

Epstein-Barr virus and oncogenesis: from latent genes to tumours

1 reference

12 December 2020

RNA interference of human papillomavirus type 18 E6 and E7 induces senescence in HeLa cells

1 reference

12 December 2020

Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease

1 reference

12 December 2020

Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.

1 reference

12 December 2020

pac gene as efficient dominant marker and reporter gene in mammalian cells

1 reference

12 December 2020

10.1007/S00432-005-0036-X

Identifiers

DOI

1 reference

19 September 2017

1 reference